Publications by authors named "Maria Zhivagui"

The somatic mutations found in a cancer genome are imprinted by different mutational processes. Each process exhibits a characteristic mutational signature, which can be affected by the genome architecture. However, the interplay between mutational signatures and topographical genomic features has not been extensively explored.

View Article and Find Full Text PDF

Ultraviolet A light is commonly emitted by UV-nail polish dryers with recent reports suggesting that long-term use may increase the risk for developing skin cancer. However, no experimental evaluation has been conducted to reveal the effect of radiation emitted by UV-nail polish dryers on mammalian cells. Here, we show that irradiation by a UV-nail polish dryer causes high levels of reactive oxygen species, consistent with 8-oxo-7,8-dihydroguanine damage and mitochondrial dysfunction.

View Article and Find Full Text PDF
Article Synopsis
  • Acrylamide, a probable carcinogen found in common sources like heated starchy foods and tobacco smoke, has been previously linked to cancer in rodents but not definitively in humans.
  • An experimental study identified a unique mutational signature caused by the reactive metabolite glycidamide, associated with acrylamide exposure.
  • This mutational signature was found in about one-third of 1,600 tumor genomes from 19 different human tumor types, with the highest presence in lung, liver, and kidney cancers, suggesting a significant role of acrylamide-related mutations in human cancers.
View Article and Find Full Text PDF

Mutation spectra in cancer genomes provide information on the disease aetiology and the causality underlying the evolution and progression of cancer. Genome-wide mutation patterns reflect the effects of mutagenic insults and can thus reveal past carcinogen-specific exposures and inform hypotheses on the causative factors for specific cancer types. To identify mutation profiles in human cancers, single-gene studies were first employed, focusing mainly on the tumour suppressor gene TP53.

View Article and Find Full Text PDF